PHR 📈 Phreesia - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US71944F1066
PHR: Scheduling, Registration, Payment, Referral, Insurance, Reminders
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware. Web URL: https://www.phreesia.com
Additional Sources for PHR Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PHR Stock Overview
Market Cap in USD | 1,490m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2019-07-18 |
PHR Stock Ratings
Growth 5y | -23.9% |
Fundamental | -37.7% |
Dividend | - |
Rel. Strength Industry | -129 |
Analysts | 4.53/5 |
Fair Price Momentum | 22.31 USD |
Fair Price DCF | - |
PHR Dividends
No Dividends PaidPHR Growth Ratios
Growth Correlation 3m | 17% |
Growth Correlation 12m | -41.2% |
Growth Correlation 5y | -52.7% |
CAGR 5y | -0.76% |
CAGR/Mean DD 5y | -0.02 |
Sharpe Ratio 12m | 0.38 |
Alpha | -21.61 |
Beta | 1.32 |
Volatility | 59.58% |
Current Volume | 749.3k |
Average Volume 20d | 480.1k |
What is the price of PHR stocks?
As of December 22, 2024, the stock is trading at USD 25.16 with a total of 749,260 shares traded.
Over the past week, the price has changed by -2.89%, over one month by +28.52%, over three months by +0.34% and over the past year by -0.67%.
As of December 22, 2024, the stock is trading at USD 25.16 with a total of 749,260 shares traded.
Over the past week, the price has changed by -2.89%, over one month by +28.52%, over three months by +0.34% and over the past year by -0.67%.
Is Phreesia a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Phreesia (NYSE:PHR) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.71 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHR as of December 2024 is 22.31. This means that PHR is currently overvalued and has a potential downside of -11.33%.
Probably not. Based on ValueRay Fundamental Analyses, Phreesia (NYSE:PHR) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.71 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHR as of December 2024 is 22.31. This means that PHR is currently overvalued and has a potential downside of -11.33%.
Is PHR a buy, sell or hold?
Phreesia has received a consensus analysts rating of 4.53. Therefor, it is recommend to buy PHR.
Phreesia has received a consensus analysts rating of 4.53. Therefor, it is recommend to buy PHR.
- Strong Buy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for PHR stock price target?
According to ValueRays Forecast Model, PHR Phreesia will be worth about 25.1 in December 2025. The stock is currently trading at 25.16. This means that the stock has a potential downside of -0.36%.
According to ValueRays Forecast Model, PHR Phreesia will be worth about 25.1 in December 2025. The stock is currently trading at 25.16. This means that the stock has a potential downside of -0.36%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 30.2 | 20.1% |
Analysts Target Price | 36.1 | 43.4% |
ValueRay Target Price | 25.1 | -0.4% |